<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="117562">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01761669</url>
  </required_header>
  <id_info>
    <org_study_id>vitamin D</org_study_id>
    <nct_id>NCT01761669</nct_id>
  </id_info>
  <brief_title>Does Deficiency in Vitamin D Induced Hypercoagulation or Thrombin Generation</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>HaEmek Medical Center, Israel</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>HaEmek Medical Center, Israel</source>
  <oversight_info>
    <authority>Israel: Ethics Commission</authority>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Working hypothesis and aims: The aim of our study is to investigate whether vitamin D
      deficiency could cause increased thrombin generation and a hypercoagulable state healthy
      volunteers.

      Methods:

      In total 400 healthy volunteers are planned for inclusion in this trial. After signing an
      informed consent two blood samples will be obtained from each participant.

      Expected results: invastigator expect to find that volunteers with vitamin D deficiency will
      have thrombin generation curve compatible with hypercoagulable state and returning to normal
      after treatment with vitamin D
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>December 2012</start_date>
  <completion_date type="Anticipated">August 2014</completion_date>
  <primary_completion_date type="Anticipated">August 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational [Patient Registry]</study_type>
  <study_design>Time Perspective: Prospective</study_design>
  <target_duration>3 Months</target_duration>
  <primary_outcome>
    <measure>the correlation between vitamin D levels and endogenous thrombin potential</measure>
    <time_frame>3 month</time_frame>
    <safety_issue>No</safety_issue>
    <description>one blood test</description>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">400</enrollment>
  <condition>Cardiovascular Disease</condition>
  <arm_group>
    <arm_group_label>healthy voulnters</arm_group_label>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Vitamin D</intervention_name>
    <arm_group_label>healthy voulnters</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        400 healthy volunteers
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria: age &gt;18 healthy naive to drug treatment -

        Exclusion Criteria:

        no exc criteria

        -
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>mazen elias, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Emek medical center</affiliation>
  </overall_official>
  <overall_official>
    <last_name>mazen Elias, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Emek medical center</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>mazen elias, MD</last_name>
    <phone>972-4-6495139</phone>
    <email>elias_m@clalit.org.il</email>
  </overall_contact>
  <location>
    <facility>
      <name>HaEmekMC</name>
      <address>
        <city>Afula</city>
        <zip>19101</zip>
        <country>Israel</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>elias mazen, prof</last_name>
      <phone>972-6495139</phone>
      <email>elias_m@clalit.org.il</email>
    </contact>
  </location>
  <location_countries>
    <country>Israel</country>
  </location_countries>
  <verification_date>May 2013</verification_date>
  <lastchanged_date>May 13, 2014</lastchanged_date>
  <firstreceived_date>December 4, 2012</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>HaEmek Medical Center, Israel</investigator_affiliation>
    <investigator_full_name>Elias mazen</investigator_full_name>
    <investigator_title>Director of Internal Medicine C</investigator_title>
  </responsible_party>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Cardiovascular Diseases</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Vitamin D</mesh_term>
    <mesh_term>Ergocalciferols</mesh_term>
    <mesh_term>Vitamins</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
